Vitamin D3

Generic Name: Vitamin D3

Brand Names: Adrovance, Animi-3 With Vitamin D, Citranatal B-calm Kit, Citranatal Harmony, Fosamax Plus D, Fosavance, Infuvite, Infuvite Pediatric, Mvc-fluoride, Natafort, Pregvit, Vidextra

Drug Type: Small Molecule

Chemical Formula: C_₂₇H_₄₄O

CAS Number: 67-97-0

Unique Ingredient Identifier: 1C6V77QF41

Background: Vitamin D, in general, is a secosteroid generated in the skin when 7-dehydrocholesterol located there interacts with ultraviolet irradiation - like that commonly found in sunlight . Both the endogenous form of vitamin D (that results from 7-dehydrocholesterol transformation), vitamin D3 (cholecalciferol), and the plant-derived form, vitamin D2 (ergocalcifero...

Indication: Cholecalciferol use is indicated for the treatment of specific medical conditions like refractory rickets (or vitamin D resistant rickets), hypoparathyroidism, and familial hypophosphatemia .
...

Associated Conditions: Bone Fractures, Calcium and Vitamin D Deficiencies, Deficiency of Vitamin D3, Deficiency, Vitamin A, Deficiency, Vitamin D, Hip Fracture, Hypoparathyroidism, Hypophosphatemia, Familial, Menopause, Osteomalacia, Osteoporosis, Postmenopausal Osteoporosis, Vertebral Fractures, Vitamin D Resistant Rickets, Vitamin Deficiency, Severe Bone Resorption, Spine fracture

Associated Therapies: Calcium supplementation, Nutritional supplementation, Vitamin D Supplementation, Vitamin supplementation

Clinical Trials

Kabul Vitamin D Supplementation Trial

Phase 3

Conditions: Pneumonia
Vitamin D Deficiency

Interventions: Drug: placebo
Drug: vitamin D

First Posted Date: 2007-10-24

Last Posted Date: 2008-05-16

Lead Sponsor: London School of Hygiene and Tropical Medicine

Target Recruit Count: 3048

Registration Number: NCT00548379

Locations: 🇦🇫
Maywand Hospital, Kabul, Afghanistan
🇦🇫
Aga Khan Health Services, Kabul, Afghanistan

Effects of Vitamin D Replacement in Patients With Primary Hyperparathyroidism (PHPT)

Phase 1

Completed

Conditions: Hyperparathyroidism

Interventions: Drug: Vitamin D
Device: Four-dimensional computed tomography (4DCT)

First Posted Date: 2007-10-03

Last Posted Date: 2019-03-25

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 22

Registration Number: NCT00538720

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Pulmonary Tuberculosis and Vitamin D

Phase 3

Conditions: Tuberculosis

Interventions: Drug: Lactose granules
Drug: Cholecalciferol

First Posted Date: 2007-07-25

Last Posted Date: 2011-01-27

Lead Sponsor: Indian Council of Medical Research

Target Recruit Count: 150

Registration Number: NCT00507000

Locations: 🇮🇳
Depratment of Endocrinology;Medicine, All India Institute of Medical sciences, and DBT, Delhi, New Delhi, India

The Effect of Calcium and Vitamin D in Patients With Heart Failure

Phase 4

Completed

Conditions: Heart Failure
Vitamin D Deficiency

Interventions: Drug: Vitamin D

First Posted Date: 2007-07-09

Last Posted Date: 2015-06-03

Lead Sponsor: Hvidovre University Hospital

Target Recruit Count: 45

Registration Number: NCT00497900

Locations: 🇩🇰
Hvidovre University Hospital, Hvidovre, Denmark

Vitamin D and Blood Pressure

Not Applicable

Withdrawn

Conditions: Hypertension

Interventions: Drug: Placebo
Drug: Vitamin D
Drug: calcitriol

First Posted Date: 2007-04-12

Last Posted Date: 2014-01-08

Lead Sponsor: Atlanta VA Medical Center

Registration Number: NCT00459563

Locations: 🇺🇸
VAMC, Decatur, Georgia, United States

Improving Vitamin D Status In Cystic Fibrosis

Not Applicable

Completed

Conditions: Cystic Fibrosis

Interventions: Drug: ergocalciferol (vitamin D2)
Device: Sperti Del Sol Lamp
Drug: Vitamin D3

First Posted Date: 2007-03-21

Last Posted Date: 2014-02-21

Lead Sponsor: Atlanta VA Medical Center

Target Recruit Count: 30

Registration Number: NCT00450073

Locations: 🇺🇸
Emory CF Center, Atlanta, Georgia, United States

Cholecalciferol (Vitamin D3) Therapy in Chronic Kidney Disease (CKD) Subjects

Not Applicable

Completed

Conditions: Vitamin D Deficiency
Chronic Kidney Disease

Interventions: Drug: Placebo
Drug: Cholecalciferol

First Posted Date: 2007-01-26

Last Posted Date: 2015-07-22

Lead Sponsor: Atlanta VA Medical Center

Target Recruit Count: 34

Registration Number: NCT00427037

Locations: 🇺🇸
Emory Clinic, Atlanta, Georgia, United States

Trial of Adjunctive Vitamin D in Tuberculosis Treatment

Phase 3

Completed

Conditions: Tuberculosis, Pulmonary

First Posted Date: 2007-01-08

Last Posted Date: 2009-09-30

Lead Sponsor: Barts & The London NHS Trust

Target Recruit Count: 146

Registration Number: NCT00419068

Locations: 🇬🇧
Whipps Cross University Hospital NHS Trust, London, United Kingdom
🇬🇧
Newham University Hospital NHS Trust, London, United Kingdom
🇬🇧
London Chest Hospital, London, United Kingdom

and more 1 locations

Vitamin D Therapy in Patients With Systemic Lupus Erythematosus (SLE)

Phase 1

Completed

Conditions: Systemic Lupus Erythematosus

Interventions: Drug: Cholecalciferol

First Posted Date: 2007-01-05

Last Posted Date: 2018-06-18

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 18

Registration Number: NCT00418587

Locations: 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

Effect of Vitamin D Supplementation on Health of Low Birth Weight Infants

Not Applicable

Completed

Conditions: Vitamin D Deficiency

Interventions: Drug: Vitamin D3

First Posted Date: 2006-12-22

Last Posted Date: 2012-08-22

Lead Sponsor: Delhi University

Target Recruit Count: 2000

Registration Number: NCT00415402

Locations: 🇮🇳
Institute of Home Economics, Delhi University, New Delhi, India

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy